[1]韩艳*,张俊娣.高危二次剖宫产出血患者宫体注射欣母沛治疗的 效果及不良反应[J].中国计划生育和妇产科,2016,(12):40-43.
 HAN Yan*,ZHANG Jun-di.Treatment effect and adverse reactions of intrauterine injection of hemabate to high-risk secondary cesarean section hemorrhage patients[J].Chinese Journal of Family Planning & Gynecotokology,2016,(12):40-43.
点击复制

高危二次剖宫产出血患者宫体注射欣母沛治疗的 效果及不良反应
分享到:

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2016年12期
页码:
40-43
栏目:
论著与临床
出版日期:
2016-12-30

文章信息/Info

Title:
Treatment effect and adverse reactions of intrauterine injection of hemabate to high-risk secondary cesarean section hemorrhage patients
作者:
韩艳*张俊娣
廊坊市人民医院医务科
Author(s):
HAN Yan*ZHANG Jun-di
Department of Medical Science, Langfang People's Hospital, Langfang Hebei 065000,P.R.China
关键词:
高危妊娠二次剖宫产产后出血欣母沛缩宫素
Keywords:
high-risk pregnancy secondary cesarean section postpartum hemorrhage hemabate oxytocin
分类号:
R 714.2
摘要:
目的探讨高危二次剖宫产出血患者宫体注射欣母沛治疗的效果及不良反应。方法选取廊坊市人民医院2013年7月至2015年11月收治的94例高危二次剖宫产患者,欣母沛组47例与缩宫素组47例,分别于剖宫产术胎儿娩出后立即给予宫体注射欣母沛或缩宫素;观察并比较两组患者术中以及术后2 h、24 h的出血量,记录两组产后出血、输血或子宫切除、不良反应等发生情况。结果欣母沛组术中以及术后2 h、24 h出血量分别为(33217±4062)mL、(11849±5144)mL、(40654±6608)mL,均少于缩宫素组(P<005);欣母沛组出现产后出血、输血、休克、子宫切除发生率分别为638 %、426 %、000 %、000 %,均低于缩宫素组(P<005);欣母沛组不良反应发生率(1064 %)低于缩宫素组(1489 %)。结论欣母沛宫体注射可以明显减少高危二次剖宫产患者的出血量,减少因大出血造成的休克、输血、子宫切除等风险;其不良反应主要为恶心、呕吐、腹泻等胃肠反应,多为暂时性且较轻微。
Abstract:
ObjectiveTo investigate the treatment effect and adverse reactions of intrauterine injection of hemabate to high-risk secondary cesarean section hemorrhage patients. Methods94 patients with high-risk secondary cesarean section were selected in Langfang People's Hospital from July 2013 to November 2015,divied into hemabate group(47 cases) and oxytocin group (47 cases).They were given intrauterine injection of hemabate and oxytocin prime immediately after childbirth of cesarean section. Observe and compare the bleeding amount of the two groups during and 2h, 24h postoperation, record postpartum hemorrhage, blood transfusion or hysterectomy,and record adverse reactions such as nausea, vomiting, gastrointestinal reaction and the occurrences. ResultsBleeding amount of the hemabate group during and 2h, 24h postoperation were (33217 + 4062) mL, (11849 + 5144) mL and (40654 + 6608)mL which were significantly lower than the oxytocin group (P<005); the incidence rates of postpartum hemorrhage, blood transfusion and shock were 638%, 426%, 000% and 000% and was significantly lower than the oxytocin group (P<005); The incidence of adverse reactions of the hemabate group( 1064%) was significantly lower than that of the oxytocin group(1489%). ConclusionIntrauterine injection of hemabate can significantly reduce the bleeding amount of high-risk secondary cesarean section hemorrhage patients,thus reduce occurrence of shock, blood transfusion and hysterectomy risk due to massive hemorrhage.Its adverse reactions mainly are nausea, vomiting, diarrhea and other gastrointestinal reactions, all temporary and mild.

参考文献/References:

[1]李雪,肖小敏 剖宫产产后出血的高危因素分析 [J] 中国妇幼保健,2010,32(6):749-751. [2] 袁力,何善阳,陈淑琴. 两种不同方法应用欣母沛预防剖宫产产后出血的临床观察 [J]. 中国妇幼保健,2010,26(34):5115-5118. [3] 黄英. 欣母沛治疗宫缩乏力性产后出血疗效观察 [J]. 中国社区医师,2014,50 (36):88-89. [4] 汪洋,谷印堂,李雪莲,等. 卡前列素氨丁三醇在预防高危孕妇产后出血中的应用效果 [J]. 中国当代医药,2015,41(13):152-154. [5] 崔芳,徐珊,黄永芳,等. 高危因素剖宫产术中三种不同用药方法预防产后出血的比较 [J]. 黑龙江医药科学,2015,57(3):70-74. [6] 吴霞,韩传宝,蒋秀红,等. 乌拉地尔用于防治剖宫产术中欣母沛不良反应的观察 [J]. 南京医科大学学报(自然科学版),2015,24(9):1305-1307. [7] 王茜,朱玉莲,吴红梅. 缩宫素联合欣母沛防治高危产妇剖宫产术后出血的疗效观察 [J]. 西部医学,2014,33(5):611-615. [8] 刘虹,王莹,温庆丽,等. 卡前列素氨丁三醇及卡前列甲酯栓促进二次剖宫产术后排气的疗效分析 [J]. 中国现代医生,2014,28(17):50-54. [9] 吴波,杨艳. 欣母沛治疗产后出血的时机选择研究 [J]. 中国妇幼保健,2014,35(22):3681-3683. [10]刘红. 欣母沛防治高危剖宫产孕妇产后出血的临床价值分析 [J]. 中国医药指南,2014,44(22):122-123. [11] 韩煜雯,郑艳莉,韩云,等. 瘢痕子宫妊娠致产后出血高危因素分析与治疗 [J]. 南通大学学报(医学版),2014,32(5):418-420. [12] 李存洁. 二次剖宫产与首次剖宫产的对照研究 [J]. 中国现代医生,2014,42(29):112-114. [13] 宫红梅,韩竞莲,于春玲. 欣母沛治疗宫缩乏力性产后出血的效果观察及护理效果评价 [J]. 中国实用医药,2016,39(2):227-228. [14] 王容. 欣母沛在瘢痕子宫阴道分娩产后出血预防中的应用 [J]. 当代医学,2016,64(11):129-131. [15] 杨柳,林炳华. 欣母沛联合宫腔填纱治疗前置胎盘剖宫产产后出血的疗效 [J]. 北方药学,2016,37(5):103-104. [16] 赵文霞,茅彩英,严琦,等. 卡前列素氨丁三醇在不同高危因素剖宫产术中预防产后出血的效果观察 [J]. 蚌埠医学院学报,2012,29(12):1454-1456.

相似文献/References:

[1]蒲杰,刘兴会*.从母婴安全角度谈新冠肺炎疫情下高危妊娠的 孕期管理[J].中国计划生育和妇产科,2020,(3):90.

备注/Memo

备注/Memo:
中国高校医学期刊临床专项资金(项目编号:115622862)
更新日期/Last Update: 2016-12-25